Icarisid II

CAS : 113558-15-9

Ref. 3D-FI73956

Informations sur le produit

• Nom: Icarisid II
• Synonymes: 3,5,7-Trihydroxy-4'-methoxyl-8-prenylflavone-3-O-rhamnopyranoside, 3-[(6-Deoxy-α-<span class="text-smallcaps">L</span>-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one, 4H-1-Benzopyran-4-one, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-, 4H-1-Benzopyran-4-one, 3-[(6-deoxy-α-<span class="text-smallcaps">L</span>-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-, 4H-1-Benzopyran-4-one, 3-[(6-deoxy-α-<span class="text-smallcaps">L</span>-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-, 5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-4-oxo-4H-chromen-3-yl 6-deoxy-alpha-L-mannopyranoside, Baohuoside 1, Baohuside I, Icariin II, Icariside II

Description

Icarisid II is a drug that has been shown to have an effect on postprandial blood glucose levels. It is used as a control method for the prevention and treatment of squamous cell carcinoma. Icarisid II also inhibits the expression of toll-like receptor 4, which plays an important role in maintaining homeostasis in the body and inhibiting tumor growth. Icarisid II was found to be more effective than icariside when combined with baohuoside for treating melanoma cells. Icarisid II may also act as an EGFR inhibitor and apoptosis pathway activator, enhancing its antitumor activity.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 514.5 g/mol
• Formule: C₂₇H₃₀O₁₀
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder